The N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan Improves Glucose Homeostasis and Preserves Pancreatic Islets in NOD Mice
Hormone and Metabolic Research · 01.03.2024 · 56 (03) · 223-234
DOI: 10.1055/a-2236-8625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.03.2024. Verfasst von Laura Wörmeyer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Islets of Langerhans. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, University Hospital Düsseldorf, Medical Faculty, Heinrich-Heine-Universität Düsseldorf.
Abstract (Originalsprache)
For treatment of type 1 diabetes mellitus, a combination of immune-based interventions and medication to promote beta-cell survival and proliferation has been proposed. Dextromethorphan (DXM) is an N-methyl-D-aspartate receptor antagonist with a good safety profile, and to date, preclinical and clinical evidence for blood glucose-lowering and islet-cell-protective effects of DXM have only been provided for animals and individuals with type 2 diabetes mellitus. Here, we assessed the potential anti-diabetic effects of DXM in the non-obese diabetic mouse model of type 1 diabetes. More specifically, we showed that DXM treatment led to five-fold higher numbers of pancreatic islets and more than two-fold larger alpha- and beta-cell areas compared to untreated mice. Further, DXM treatment improved glucose homeostasis and reduced diabetes incidence by 50%. Our data highlight DXM as a novel candidate for adjunct treatment of preclinical or recent-onset type 1 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
- Institute of Metabolic Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
- Institute for Vascular and Islet Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
- German Center for Diabetes Research (DZD e.V.), Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- University Hospital Düsseldorf, Medical Faculty
- Heinrich-Heine-Universität Düsseldorf
Zitieren
APA
Wörmeyer, L., Nortmann, O., Hamacher, A., Uhlemeyer, C., Belgardt, B., Eberhard, D., Mayatepek, E., Meissner, T., Lammert, E., & Welters, A. (2024). The N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan Improves Glucose Homeostasis and Preserves Pancreatic Islets in NOD Mice. Hormone and Metabolic Research, 56(03), 223-234. https://doi.org/10.1055/a-2236-8625
Vancouver
Wörmeyer L, Nortmann O, Hamacher A, Uhlemeyer C, Belgardt B, Eberhard D, et al. The N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan Improves Glucose Homeostasis and Preserves Pancreatic Islets in NOD Mice. Hormone and Metabolic Research. 2024;56(03):223-234. doi:10.1055/a-2236-8625
BibTeX
@article{Wrmeyer2024,
author = {Wörmeyer, Laura and Nortmann, Oliver and Hamacher, Anna and Uhlemeyer, Celina and Belgardt, Bengt and Eberhard, Daniel and Mayatepek, Ertan and Meissner, Thomas and Lammert, Eckhard and Welters, Alena},
title = {The N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan Improves Glucose Homeostasis and Preserves Pancreatic Islets in NOD Mice},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {03},
pages = {223--234},
doi = {10.1055/a-2236-8625}
}
EUVIMED